Underlying NIDCR’s Financial Management Plan is the Institute’s goal to provide stable levels of support for high quality scientific research and research training. NIDCR is currently operating under the Continuing Appropriations Act, 2021 and Other Extensions Act (Public Law 116-159) signed by the President on October 1, 2020. This Act (CR) continues government operations through December 11, 2020 at the FY 2020 enacted level. Consistent with NIH policy, NIDCR will fund non-competing continuation research grant awards at 90% of the previous commitment level indicated on the most recent Notice of Award. Upward adjustments to awarded levels will be considered after FY 2021 appropriations are enacted.
The NIDCR will continue to provide individual consideration to all competing applications. For all competing R01 applications selected for funding, the NIDCR will reduce applications by 5 percent below the peer review recommended level of support. As the year progresses, the Institute adjusts its plans to take into account the scientific merit of applications as reflected in the scores assigned during peer review, new scientific opportunities, changes in the projected number of applications, projected award costs, and other relevant factors. Consistent with the NIH Next Generation Researchers Initiative, NIDCR is committed to support a robust and diverse workforce through additional funding consideration for supporting Early Stage Investigators (ESIs) and At-risk Investigators.